Corient Capital Partners, LLC Insulet Corp Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Insulet Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 1,122 shares of PODD stock, worth $301,885. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,122
Previous 1,122
-0.0%
Holding current value
$301,885
Previous $245,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding PODD
# of Institutions
687Shares Held
64.9MCall Options Held
388KPut Options Held
795K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.28 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.09 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.63 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$784 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$612 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $18.7B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...